SKN | Julius Baer Zurich Establishes $1.24 Million Position in MetLife as Insurer Reports Strong Quarterly Results

Key Takeaways:

• Bank Julius Baer & Co. Ltd Zurich acquired 13,020 MetLife shares during the third quarter, establishing a new position valued at approximately $1.24 million.
• MetLife reported adjusted quarterly earnings of $2.78 per share, exceeding the $2.77 analyst consensus, while revenue increased 18.2% year over year to $20.52 billion.
• MetLife has authorized a $3 billion share-repurchase programme and declared a quarterly dividend of $0.5925 per share, while analysts maintain a consensus Moderate Buy rating with an average price target of $105.44.

Julius Baer Establishes New MetLife Position

Bank Julius Baer & Co. Ltd Zurich acquired a new position in MetLife, Inc. during the third quarter, according to its latest filing with the US Securities and Exchange Commission.

The Swiss financial institution purchased 13,020 shares of the US-based insurance and financial services provider, representing an investment valued at approximately $1.24 million.

The transaction adds MetLife to Julius Baer’s reported institutional holdings and reflects portfolio exposure to a major provider of insurance, retirement and employee benefit solutions.

Julius Baer’s investment forms part of broader institutional activity surrounding MetLife. BlackRock established a position valued at approximately $4.38 billion during the second quarter, while Pzena Investment Management acquired shares worth approximately $941.8 million. UBS Asset Management increased its holdings by 5.9% to 6,026,518 shares, valued at approximately $509.9 million.

Bank of America established a position valued at approximately $455.4 million, while Legal & General Group acquired a new stake worth approximately $326.9 million.

Institutional investors and hedge funds collectively own approximately 94.99% of MetLife’s outstanding shares, indicating substantial institutional participation in its shareholder base.

Earnings Growth and Revenue Performance

MetLife reported its third-quarter 2026 financial results on November 4, delivering adjusted earnings of $2.78 per share. The figure exceeded the analyst consensus estimate of $2.77 and compared with $2.34 per share in the corresponding period a year earlier.

Quarterly revenue reached $20.52 billion, compared with analyst expectations of $19.86 billion. The company reported year-over-year revenue growth of 18.2%.

The results indicate continued earnings and revenue expansion, although the available reporting does not provide sufficient segment-level detail to determine which business lines contributed most significantly to the performance.

MetLife also reported a return on equity of 23.39% and a net profit margin of 4.57%. Analysts currently forecast full-year earnings of approximately $9.94 per share.

For institutional investors, the combination of earnings growth, profitability indicators and a substantial international insurance platform provides a basis for evaluating the company’s operating performance and shareholder-return capacity.

Analyst Sentiment and Valuation Expectations

Research coverage remains broadly positive, with 13 analysts assigning MetLife a Buy rating and two maintaining Hold recommendations. MarketBeat data places the overall consensus at Moderate Buy, with an average price target of $105.44.

Several research institutions have recently adjusted their expectations:

• UBS Group raised its price target from $105 to $110 and maintained a Buy rating.
• JPMorgan Chase increased its target from $108 to $110 and assigned an Overweight rating.
• Barclays raised its target from $97 to $111, also maintaining an Overweight recommendation.
• Argus increased its target from $93 to $109 and retained a Buy rating.
• Atlantic Securities established a $103 price objective.

The revised targets indicate generally constructive analyst expectations, although price objectives remain estimates rather than guarantees of future share performance.

Share Performance and Capital Allocation

MetLife shares opened at $102.84 on Thursday, with the company carrying a reported market capitalization of approximately $66.17 billion.

The stock had a 12-month trading range of $67.33 to $103.65. Its 50-day moving average stood at $98.05, while the 200-day moving average was $86.03.

The reported valuation metrics included a price-to-earnings ratio of 10.30, a PEG ratio of 0.95 and a beta of 0.79. The company also reported a debt-to-equity ratio of 0.52.

MetLife’s capital allocation strategy includes a $3 billion share-repurchase authorization approved by its board on August 5. The programme permits the company to repurchase up to 4.8% of its outstanding shares through open-market purchases.

Share repurchases can reduce the number of outstanding shares and influence earnings per share, although their long-term value depends on the price paid, capital requirements and competing investment priorities.

Dividend Policy and Shareholder Returns

MetLife also declared a quarterly dividend of $0.5925 per share, payable on December 8 to shareholders of record on November 3. The ex-dividend date was also November 3.

The distribution represents an annualized dividend of $2.37 per share and a reported yield of approximately 2.3%. The company’s payout ratio stood at 45.40%.

The combination of dividends and the authorized repurchase programme provides two channels through which MetLife intends to return capital to shareholders.

For institutional investors and wealth managers, the sustainability of these distributions remains linked to earnings generation, capital adequacy, insurance liabilities and the company’s broader financial commitments.

MetLife’s Global Insurance and Financial Services Platform

MetLife is a global financial services company providing insurance, retirement and employee benefit solutions to individuals, employers and institutions.

Its product portfolio includes life insurance, dental and vision coverage, accident and disability insurance, annuities, retirement savings products and related financial services.

Through its institutional and workplace businesses, the company supports employers in providing employee benefits and retirement programmes. Its individual business serves customers seeking financial protection and income-related products.

This diversified operating model positions MetLife across several areas of the financial services industry, including protection, long-term savings and workplace benefits. These activities also expose the company to evolving demographic trends, insurance claims experience, investment-market conditions and retirement planning requirements.

Closing Insights

Julius Baer’s approximately $1.24 million investment adds another institutional position to MetLife’s shareholder base at a time when the insurer is reporting higher quarterly earnings and revenue growth. The company’s substantial institutional ownership, positive analyst consensus and shareholder-return programme provide additional context for evaluating its position in the global insurance sector.

Looking ahead, investors will need to monitor the sustainability of earnings growth, the performance of MetLife’s insurance and retirement businesses, and the relationship between capital returns and regulatory capital requirements. The execution of the $3 billion repurchase authorization and the company’s ability to maintain dividend distributions will also remain relevant indicators of its capital allocation priorities.

For wealth managers, MetLife’s business model illustrates the continuing role of large insurance institutions in providing protection, retirement and employee benefit solutions across international markets.

For a confidential discussion regarding retail banking strategy, insurance distribution models, customer loyalty ecosystems, digital financial services, or cross-border financial innovation opportunities, contact our senior advisory team.